The compound GR127935, which ranked second, is a 5-hydroxytryptamine (5-HT) receptor antagonist that primarily binds to the 5-HT1A, 5-HT2A, and 5-HT7 receptors and has been widely studied in neurological disease research. Here, HTR1A is linked to nervous system disorder.